A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

March 31, 2029

Study Completion Date

March 31, 2029

Conditions

Age-Related Macular Degeneration

Interventions

DRUG

RetinoStat

Long Term Follow up of patients who received RetinoStat in a previous study

Trial Locations (3)

University of Iowa Hospitals & Clinics, Iowa City

Oregon Health & Science University, Portland

John Hopkins University Hospital, Baltimore